Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Auris Nasus Larynx ; 40(4): 366-72, 2013 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-23107100

RESUMO

OBJECTIVE: The objective is to determine the appropriate duration of postoperative macrolide therapy for chronic rhinosinusitis to obtain a favourable outcome with endoscopic sinus surgery (ESS). METHODS: The effectiveness of postoperative macrolide treatment was examined in patients with chronic rhinosinusitis who underwent ESS, by comparing 3-month (44 patients) and 6-month administration (66 patients) of clarithromycin (CAM) (200mg/day). Evaluation was made based on subjective symptoms and endoscopic findings at 3, 6 and 12 months after surgery. RESULTS: Seventeen (3-month CAM group) and 22 (6-month CAM group) subjects were able to be followed up to 12 months after surgery. No difference in effectiveness was observed between the groups until 6 months after surgery, but the 6-month treatment group showed significantly higher disappearance rates and significantly lower visual analogue scale (VAS) scores in the subjective symptoms of rhinorrhea and postnasal drip at 12 months after surgery. The positive finding rate of postnasal drip by endoscopic examination was also significantly lower in the 6-month treatment group at 12 months after surgery. These changes over time indicated gradual deterioration after discontinuation of CAM treatment in the 3-month treatment group, whereas a small improvement was observed after discontinuation in the 6-month treatment group. CONCLUSION: The results indicate that chronic sinusitis patients with rhinorrhea or postnasal drip should be treated with macrolides for 6 months after surgery in order to improve the long-term outcome of endoscopic sinus surgery.


Assuntos
Antibacterianos/administração & dosagem , Claritromicina/administração & dosagem , Seios Paranasais/cirurgia , Rinite/tratamento farmacológico , Sinusite/tratamento farmacológico , Adulto , Idoso , Doença Crônica/terapia , Terapia Combinada , Endoscopia , Humanos , Pessoa de Meia-Idade , Procedimentos Cirúrgicos Otorrinolaringológicos , Rinite/cirurgia , Sinusite/cirurgia , Fatores de Tempo , Resultado do Tratamento , Adulto Jovem
2.
Acta Otolaryngol ; 131(7): 684-91, 2011 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-21526906

RESUMO

CONCLUSION: Our herpes simplex virus (HSV) labyrinthitis mouse model suggests that HSV infection induces vestibular neuritis and sudden deafness. OBJECTIVE: Viral labyrinthitis has been postulated to play a role in vestibular neuritis and sudden deafness. We established a mouse model to investigate the pathogenesis of HSV-induced labyrinthitis. The relationship between HSV infection and apoptosis in the labyrinth was assessed. METHODS: HSV types 1 and 2 were inoculated into the middle ear of mice, and the function of the cochlear and vestibular nerves was assessed. Histopathological changes were examined with hematoxylin and eosin staining. Anti-HSV immunohistochemistry staining and TUNEL staining were done to investigate the relationship between HSV-infected cells and apoptotic cells. RESULTS: Hearing loss and vestibular dysfunction were observed in all mice after inoculation of HSV type 1 or 2. In the cochlear duct, columnar epithelial cells in the stria vascularis were infected with HSV, but only a portion of the infected cells underwent apoptosis. In contrast, many uninfected cells in the spiral organ of Corti were apoptotic. Vestibular dysfunction was observed when vestibular ganglion cells were largely infected, but not apoptotic. These findings recapitulate sudden deafness and vestibular neuritis described in patients.


Assuntos
Perda Auditiva Súbita/etiologia , Herpes Simples/complicações , Labirintite/complicações , Laringite/complicações , Neuronite Vestibular/etiologia , Animais , Cóclea/patologia , DNA Viral/análise , Modelos Animais de Doenças , Feminino , Herpes Simples/virologia , Herpesvirus Humano 1/genética , Labirintite/patologia , Labirintite/virologia , Laringite/virologia , Camundongos , Camundongos Endogâmicos ICR , Nervo Vestibular/patologia , Nervo Vestibular/virologia , Vestíbulo do Labirinto/patologia , Vestíbulo do Labirinto/virologia
4.
Ann Otol Rhinol Laryngol ; 111(11): 1054-8, 2002 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-12450184

RESUMO

In order to study the efficacy of surgical intervention, as well as the influence of cigarette smoking on olfaction in clinical states, we examined olfactory ability by means of the University of Pennsylvania Smell Identification Test (UPSIT). We enrolled 37 patients 21 to 60 years of age who underwent surgery for chronic sinusitis. Normosmia was defined as an UPSIT score of 30 or more. Among these patients, 31 had a disturbance in their smelling ability in the preoperative stage, and the improvement rate, defined as a rise in score of 4 or more points after surgery, was 64.5%; 11 were well healed. However, all 7 patients who were more than 40 years old at the time of surgery, and currently smoking cigarettes, had a significant deficit in olfaction in the preoperative stage and even in the postoperative stage. This study demonstrated that cigarette smoking has adverse effects on olfactory ability, especially for older patients.


Assuntos
Endoscopia , Transtornos do Olfato/etiologia , Sinusite/cirurgia , Olfato , Fumar/efeitos adversos , Adulto , Fatores Etários , Doença Crônica , Interpretação Estatística de Dados , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Transtornos do Olfato/diagnóstico , Período Pós-Operatório , Prognóstico , Sinusite/complicações , Sinusite/diagnóstico por imagem , Fatores de Tempo , Tomografia Computadorizada por Raios X
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA